Health Letter Volume Index

January 1997 - September 2009

Issues are not available online, but print copies are available for $3.00 each. Subscriptions are available for $18 per year.  To order, please send a check (payable to Public Citizen) to Health Research Group, 1600 20th Street NW, Washington, DC 20009, or you can order by phone with a major credit card at (202) 588-1000.


September 2009, V25#9

  • Obama Administration Must Make Disciplinary Records of Nurses, Health Workers Available to Hospitals, Nursing Homes
  • Letter Urging Secretary Sebelius to Provide Hospitals and Nursing Homes Access to Names of Disciplined Nurses and Other Health Workers
  • A Call to Action: Why We Need Medical Resident Work Hour Reform
  • Product Recalls
  • Are We Now Twice as Sad? The Drug Industry and Doctors Think We Are!
  • Outrage: Ghostly Prescriptions

August 2009, V25#8

  • Dr. Sidney Wolfe’s Testimony before Subcommittee on Health at Hearing on Health Insurance
  • Dr. Steffie Woolhandler’s Testimony before Health Subcommittee at Hearing on Health Insurance
  • Letter to the Editor of the Washington Post Regarding the Coverage of the Recent Congressional Hearing on Single-Payer
  • Ineffectual Medical Treatments Misleadingly Produce “Good” Results
  • Product Recalls
  • Outrage: Medical Publisher Offers Bribes for Writing Favorable Book Reviews

July 2009, V25#7

  • Q & A on the Current Health Debate: What Does a ‘Public Plan Option’ Mean and Why Does Public Citizen Oppose it?
  • Hospitals Drop the Ball on Physician Oversight
  • A Dictionary of Health Policy Terms, Part III
  • Product Recalls
  • Outrage: Language Matters: Poor Communication Can Mean Poor Health Care

June 2009, V25#6

  • Vermont’s Pharmaceutical Laws Move Toward Fuller Disclosure
  • What is Comparative Effectiveness Research, and Why is it Being Badmouthed?
  • Intro to Comparative Health Systems
  • Product Recalls
  • Outrage: A Coalition of the Scared

May 2009, V25#5

  • Public Citizen’s Health Research Group Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2006-2008
  • Product Recalls
  • Outrage: Psychoprostitution

April 2009, V25#4

  • Stretching the TARP to Cover Health Care
  • Bereavement: A Look at the Grieving Process and How to Cope with Loss
  • Product Recalls
  • How Much Is A Year of Your Life Worth?
  • WARNING: MRI Scans May Burn Patients Wearing Transdermal Drug Patches
  • Outrage: High Deductibles for Limited Eligibles

March 2009, V25#3

  • Massachusetts’ Plan: A Failed Model for Health Care Reform
  • Product Recalls
  • Having Health Insurance Does Not Mean Having Health Care
  • Public Hospitals, Community Clinics Suffering Under Massachusetts Health Care Reform
  • Outrage: Ending the Insanity of Failed State Health Insurance Reforms

February 2009, V25#2

  • Our Perfectly Designed U.S. Healthcare System
  • Public Citizen Endorses Single Payer National Health System, Joins Leadership Conference for Guaranteed Health Care
  • U.S. Inmates Suffer from Chronic Illness and Poor Access to Health Care
  • Informed Consent and Shared Decision-Making
  • Product Recalls
  • Outrage: “Morning After” Contraception Too Difficult to Get

January 2009, V25#1

  • Single Payer Health Care in Taiwan: Borrowing Ideas, Improving on Medicare
  • Health Letter Volume Index, 2008
  • Indulgence and Innovation in Medical Care
  • Product Recalls
  • Smokeless Tobacco: Rebranding Nicotine, Repackaging Death
  • Outrage: Full Body Scams: Not Your Source for Peace of Mind

December 2008, V24#12

  • In Case You Missed It: What Happened in Health in 2008
  • Calculating Your Risk of Death from Disease and Accidents
  • Product Recalls
  • Outrage: Is the Uterus a Pre-Existing Condition?

November 2008, V24#11

  • The Uninsured in the United States: What the Drop to 45.7 Million Means
  • Pharma Should Not Foot the Bill for Your Doctor’s Continuing Medical Education
  • Weighing Conscience Protection Against a Patient’s Right to Information
  • Product Recalls
  • Outrage: Mongering Diseases to Hawk Pills: The Case of Fibromyalgia

October 2008, V24#10

  • A Tale of Three Cities: Racial and Ethnic Disparities in Premature Mortality in the District of Columbia, 2005
  • Product Recalls
  • Outrage: Big Tobacco Targets College Students

September 2008, V24#9

  • Long-Term Care Insurance: Perennial Questions, Updated Answers
  • Product Recalls
  • Outrage: Athletic Prowess and the Doping of Consumers

August 2008, V24#8

  • Unseen Payoffs and the Poverty of Prevention
  • Just How Does the U.S. Health Care System Stack Up?
  • Product Recalls
  • "Mistakes Were Made": Disclosing Medical Errors
  • Outrage: Botox, Mark Spitz, Nadia Comenici and Willie Nelson

  July 2008, V24#7

  • What Are Presidential Candidates (And Their Advisors) Talking About? Part II
  • Macular Degeneration
  • Product Recalls
  • Outrage: Why is Darvon (Darvocet/propoxyphene) Still Around, Hurting People?

June 2008, V24#6

  • Drug Research: To Test or to Tout?
  • Backsliding on Childhood Immunizations
  • Public Citizen Urges Removal of Ortho-Evra Patch from Market
  • Product Recalls
  • Study Finds New Blood Substitutes Increase Risk of Death, Heart Attacks; Authors Question FDA’s Approval Process, Records Access
  • Outrage: Human Experimentation and Speedy For-Profit Ethical Review Boards

May 2008, V24#5

  • Health Policy Placebos
  • Physician Support for National Health Insurance on the Rise
  • Public Citizen’s Health Research Group Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2005-2007
  • Product Recalls
  • Outrage: "Physician, Heal Thyself" Not Always Simple

April 2008, V24#4

  • Medical Errors and State Reporting of Adverse Events
  • Public Citizen Testifies on Drug Safety Before Congress
  • Product Recalls
  • Outrage: Unnecessary Medical Radiation: Children the Most Vulnerable

March 2008, V24#3

  • Medical Records: Q&A
  • Public Citizen Launches Now Blog
  • Market-Based Failure: A Second Opinion on U.S. Health Care Costs
  • Product Recalls
  • Outrage: Scarce Kidneys: Why U.S. Transplantation Policies Are Inherently Inequitable and How They Can Be Changed

February 2008, V24#2

  • Lost in Translation: Why the Highly-Touted Dutch Health System Would Not Be a Good Idea for the U.S.
  • Product Recalls
  • Outrage: Drug Industry Spends Almost Twice As Much on Promotion of Drugs As on Research

January 2008, V24#1

  • Boundaries Without Barriers: Cross-Border Health in the European Union
  • Product Recalls
  • Health Letter Volume Index 2007 and Cumulative Index
  • Outrage: Pay for Performance: Incentives Gone Awry

December 2007, V23#12

  • What Happened in U.S. Health Care in 2007?
  • Update on Avandia
  • Product Recalls
  • MedWatch
  • Outrage: Illegal Kickbacks From Artificial Knee and Hip Manufacturers to Orthopedic Surgeons

  November 2007, V23#11

  • Rethinking Health Care for the Elderly
  • More Than A Prayer for Single Payer
  • Product Recalls
  • Another U.S. Go-It-Alone Policy
  • Outrage: "Reminder Ads": Innuendo Minus Information

  October 2007, V23#10

  • Equal Pay for Equal Work? Not For Medicaid Doctors
  • Hoodia: Another Weight Loss Scam
  • Product Recalls
  • Research as Public Relations
  • Outrage: Are Hospitals Making Us Sicker?

September 2007, V23#9

  • Improving Public Access to Clinical Trial Information
  • Scapegoating Immigrants
  • Product Recalls
  • The Latest Data on the Uninsured
  • Outrage: Manipulating the Hispanic Market: The Case of Viagra

August 2007, V23#8

  • What Are The Presidential Candidates Talking About?: A Brief Dictionary of Health Policy Terms
  • Product Recalls
  • Now, Let the Victim Beware
  • Taming Technology
  • Outrage: Our Health Care System

July 2007, V23#7

  • Q&A on the Human Papilloma Virus Vaccine Gardasil
  • Product Recalls
  • Organ Donations: What Price, The Priceless?
  • Taming the Giant Corporation
  • Outrage: PDUFA: Buying Votes, Selling Unsafe Products

June 2007, V23#6

  • Public Citizen’s Ranking of State Medical Boards’ Serious Disciplinary Actions, 2004-2006
  • Product Recalls
  • Outrage: Avandia: Not-So-New News of Heart Problems With the Popular Diabetes Drug

May 2007, V23#5

  • Back to Basics: Clean Water as a Medical Milestone
  • Doctors and Drug Company Favors
  • Drugs for Weight Loss
  • Product Recalls
  • Do Not Use Dextromethorphan
  • Outrage: What’s Wrong With This Story?: Pharmaceutical Company Files Sales Director for Telling the Truth

April 2007, V23#4

  • Unsettling Scores: A Ranking of State Medicaid Programs
  • Product Recalls
  • Outrage: Walling Off Medicaid Beneficiaries

March 2007, V23#3

  • Public Citizen Petitions FDA to Ban Third-Generation Oral Contraceptives
  • Product Recalls
  • Cough and Cold Meds Send Babies to Hospital
  • American Life Expectancy on Rise
  • Colds: How to Treat Them
  • Outrage: And The Oscar for Best Drugumentary Goes To…

  February 2007, V23#2

  • Medicaid @ 40: Why It Matters
  • Work and Wellness: Collusion or Collision?
  • A Statement by Dr. Sidney Wolfe, Health Letter’s Editor-in-Chief
  • Conflicts of Interest: An Issue That Will Not Go Away
  • Product Recalls
  • Conflicts of Interest Among Clinical Investigators
  • Outrage: Essay: What’s Making Us Sick Is an Epidemic of Diagnoses

January 2007, V23#1

  • Dr. Wolfe’s Diet Revolution
  • Product Recalls
  • Health Letter Volume Index 2006 and Cumulative Index
  • Outrage: Conflicts of Interest: The Hidden Side of Science

Volume 22, Number 12, December 2006

  • Report of Doctor Disciplinary Information on State Web Sites: A Survey and Ranking of State Medical and Osteopathic Board Web Sites in 2006
  • Product Recalls
  • What If We Were Equal?

Volume 22, Number 11, November 2006

  • New York City’s Answer to the Diabetes Epidemic: Screen, Trace, Track and Act: More Public Health, Fewer Pharmaceuticals
  • A Broader Context: Diabetes in the United States and in the World
  • What is Diabetes?
  • Bogus Cures for Diabetes on the Internet
  • The New York City Department of Health’s Recommendations for Living with Diabetes
  • Product Recalls
  • Diabetes in the U.S.: The Epidemic in Numbers
  • Placing the Promise of Prevention in Context: The Case against the Diabetes Drug Rosiglatizone (Avandia)

Volume 22, Number 10, October 2006

  • Crime and Punishment, Medical Style
  • The US FDA at a Crossroads
  • No “Alternative”
  • Product Recalls
  • The Number of Uninsured in the United States Reaches 46.6 Million

Volume 22, Number 9, September 2006

  • The Changing Dynamics of C-Sections in the United States: Cesarean Delivery on Maternal Request: Part II
  • Patients Without Borders:: The Emergence of Medical Tourism: Part II
  • The “Ultimate Prize” for Big Tobacco: Opening the Chinese Cigarette Market by Cigarette Smuggling
  • Product Recalls
  • Fairness Creams in South Asia: A Case of Disease Mongering?

Volume 22, Number 8, August 2006

  • Health Care Reform in the United States: Arguments for a Single Payer System
  • The Changing Dynamics of C-Sections in the United States: Part I
  • Product Recalls
  • Pharmaceutical Marketing and the Invention of the Medical Consumer

Volume 22, Number 7, July 2006

  • Patients Without Borders: The Emergence of Medical Tourism
  • Study Finds Many Favor A Single Payer System
  • Product Recalls
  • Much-Needed Corrective Lenses for the “Clinical Eye”
  • Laser Therapy for Smoking: Shining a Laser on Bad Advertising Practices
  • The Growing Gap in Reproductive Health

Volume 22, Number 6,  June 2006

  • Public Citizen’s Health Research Group Ranking of State Medical Board Disciplinary Actions: 2003-2005
  • Poll: People Understand Systemic Problems at FDA
  • Product Recalls
  • Exercise Status and Future Dementia
  • Study Finds Glucosamine, Chondroitin Ineffective for Joint Pain
  • Outrage: Pharmaceuticals Need Price Controls

Volume 22, Number 5, May 2006

  • The Fight against Disease Mongering
  • From Unease to Disease
  • Blurring the Boundaries between Health and Illness
  • Product Recalls
  • Massachusetts’ Mistake

Volume 22, Number 4, April 2006

  • Hearing Aids: Why Medicare Should Provide Coverage
  • Despite New Study, Crestor Should Not Be Prescribed
  • Product Recalls
  • Chromium Industry Withheld Data from OSHA
  • Outrage: Darvon and Darvocet: What Are They Thinking?

Volume 22, Number 3, March 2006

  • Drugs Used to Treat High Blood Pressure
  • Elevated Cholesterol Levels
  • Who Needs Nondietary Potassium Supplementation?
  • Product Recalls
  • Outrage: Health Care Quality?

Volume 22, Number 2, February 2006

  • High Blood Pressure
  • The High Cost of Cancer Treatment
  • Product Recalls
  • Preventing Dementia with Exercise
  • Outrage: Why Over-the-Counter? Diet Drug Poses Risks, Questionable Benefits

Volume 22, Number 1, January 2006

  • Saving Money When Buying Prescription Drugs: Part III: Caution When Purchasing Drugs on the Internet
  • Recall Update
  • Product Recalls
  • Health Letter Volume Index 2004 and Cumulative Index
  • Outrage: Medicare Part D: What Benefit?

Volume 21, Number 12, December 2005

  • Drivel from the Drug Industry/U.S. Government Axis
  • Saving Money When Buying Prescription Drugs, Part II: Generic Drugs
  • Product Recalls
  • Outrage: Second Chances: Big Tobacco Enters the Health Care Industry

Volume 21, Number 11, November 2005

  • Curbing the Influence of the Drug Industry: A British View
  • Saving Money When Buying Prescription Drugs
  • Product Recalls
  • Public Citizen Writes of Drug Company Deception in Lancet Medical Journal
  • FDA Reverses Course of Needle Sticks, Shows Profound Indifference to Worker Health
  • Outrage: Helping Drug Reps Serve You Better: National Healthcare Census

Volume 21, Number 10, October 2005

  • FDA Device Regulation Leaves Unsafe Products on Market: Public Citizen Petitions for Better Rules
  • Antibiotic Clarithromycin (BIAXIN) Can Have Deadly Interaction with Anti-Gout Drug Colchicine
  • Product Recalls
  • Three Misleading Direct-to-Consumer Ad Campaigns
  • Insurers Have it Wrong on Malpractice—Again
  • Industry Drug Guidelines Will Do Little to Prevent Misleading Ads

Volume 21, Number 9, September 2005

  • New “Diseases”: Often Invented by Drug Industry Marketing Departments to Sell You Drugs
  • Ten Additional Causes of Medical Malpractice Lawsuits
  • Preventing the Epidemic of Skin Cancer: A Guide for Protecting Yourself and Your Family
  • Product Recalls
  • Asthma Medicines That Can Cause Asthma Attacks: Do Not Use Serevent, Advair, or Foradil
  • Outrage: FDA Denial of Public Citizen’s Petition to Ban Meridia is Misguided

Volume 21, Number 8, August 2005

  • Sleight-of-Hand: Merck Contemplated Vioxx Reformulation in 2000 While Denying Risk
  • Can I Buy You Dinner? Pharmaceutical Companies Increasingly Use Doctors’ Talks as Sales Pitches
  • Product Recalls
  • Pennsylvania Data Show Large Number of Hospital-Acquired Infections
  • Decreased Child Mortality a Possibility with Appropriate Funding, Study Shows
  • FDA Issues Guidelines for Consumer Prescription Drug Information
  • FDA Approves Depression Device Without Proof of Effectiveness
  • Outrage: Warning: Contains FDA-Approved Drug…

Volume 21, Number 7, July 2005

  • Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies
  • Scientific Misconduct: Rare or Rampant?
  • Product Recalls
  • Successfully Pushing Paxil on Television
  • Outrage: Drug Rep (salesman) vs. Dr. Grobstein

Volume 21, Number 6, June 2005

  • Ranking the State Medical Boards’ Serious Disciplinary Actions: 2002-2004
  • Product Recalls
  • Outrage: Repeat Malpractice Offenders Compromise Patient Safety

Volume 21, Number 5, May 2005

  • In Memoriam: Bill Hines, 1917-2005
  • “…Makes You Stop and Think”
  • Product Recalls
  • HMO-Medicare Crisis: Is Health Insurance for the Elderly on the Way Out?
  • Outrage: The Causes of Misprescribing and Overprescribing

Volume 21, Number 4, April 2005

  • George A. Silver, M.D., 1913-2005: In Memoriam
  • Misprescribing and Overprescribing of Drugs
  • Product Recalls
  • Outrage: The Problem Is…

Volume 21, Number 3, March 2005

  • Medical Liability Reform? FDA Does Not Adequately Protect Consumers
  • Illness and Medical Bills Cause Half of All Bankruptcies
  • Product Recalls
  • Outrage: Get the Lead Out

Volume 21, Number 2, February 2005

  • Nine Reasons Why Older Adults Are More Likely Than Younger Adults to Have Adverse Drug Reactions
  • Product Recalls
  • Bereavement
  • Outrage: Take Drugs Off the Market

Volume 21, Number 1, January 2005

  • Health Care: Beyond Markets
  • Product Recalls
  • Health Letter Volume Index 2004 and Cumulative Index
  • Outrage: HHS Fails to Warn About Preventing Falls in Older Adults

Volume 20, Number 12, December 2004

  • Single Payer: Good for Business
  • The View From Vermont

Volume 20, Number 11, November 2004

  • America’s Neglected Veterans: 1.7 Million Who Served Have No Health Coverage
  • Blockbuster Arthritis Drug Rofecoxib (VIOXX) Withdrawn From Market: Worst Pills, Best Pills News Readers Warned in 2001: DO NOT USE
  • Screening for Colon Cancer: Insurance Coverage Still Spotty
  • “Stealth PACs” Give Drug Industry Big Bang for Its Bucks

Volume 20, Number 10, October 2004

  • Cheap Trick: Bush’s health-savings accounts are a bargain—provided you never get injured or sick
  • You Have Reached the Medicare Program. Please Hold for the Next Available Source of Inaccurate Information.
  • Discovering Health Care Fraud and “Telling”: Whistleblowers

Volume 20, Number 9, September 2004

  • Blood Safety
  • Why is the U.S. So Far Behind on Prescription Drug Price Controls?
  • DO NOT USE! Lawsuit Reveals Serious Safety Problems With The Nonsteroidal Anti-inflammatory Drug (NSAID) Valdecoxib (BEXTRA)
  • Even Moderate Amounts of Exercise Can Prevent Weight Gain
  • DO NOT USE! Long-Term Treatment with The Alzheimer’s Disease Drug Donepezil (ARICEPT) Ineffective
  • Weapons of Mass Destruction and Medicine

Volume 20, Number 8, August 2004

  • The People Have Spoken: The Drug Industry Doesn’t Serve Us Well
  • Boutique Medicine (Concierge Care) Revisited
  • Doctor Bribing in Italy
  • Suicide Risk Added To The Professional Product Labeling For Eight Antidepressants
  • DO NOT USE—Save Your Money: Dextromethorphan (DELSYM or generic) Or Diphenhydramine (BENADRYL or generic) Ineffective for Nighttime Cough in Children
  • Outrage: Medizine: Drug Ads Masquerading as News

Volume 20, Number 7, July 2004

  • The High Costs of For-Profit Care
  • It Takes Two to Tango (or to Bribe): Big-Time Crime in the Pharmaceutical Industry with the Help of Doctors
  • Regular Exercise May Prolong Your Life
  • The Wild, Wild Web for Prescription Drugs
  • Outrage: Breast Implants as High School Graduation Presents: Just Poor Parenting or Child Abuse?

Volume 20, Number 6, June 2004

  • Patent Fiction
  • National Health Insurance: Falling Expectations and the Safety Net
  • DO NOT USE! Dangerous Drug for Irritable Bowel Syndrome: Constipation Predominant Tegaserod (ZELNORM)
  • Improper Antibiotic Treatment for Bladder Infections
  • Outrage: Serious and Growing Problem of Antibiotic Resistance

Volume 20, Number 5, May 2004

  • Public Citizen’s Health Research Group Ranking of State Medical board Serious Disciplinary Actions in 2003
  • The Antidepressant Fluoxetine (PROZAC) and Suicidal Ideation—Déjà vu 1991
  • Saline Spray: Do Try This at Home
  • Outrage: FDA Frustrates the Intent of Congress for 17 Years

Volume 20, Number 4, April 2004

  • Prescriptions and Profit
  • Publicity about Recent Studies on the Cholesterol-lowering Statin Drugs: Misinterpretations
  • Direct-to-Consumer Advertising: Bad News for Most Patients and Doctors
  • Comments of a Canadian Doctor: After 10 years, has anything really changed for the better?
  • Outrage: Serious Concerns about a Portable Ventilator (respirator)

Volume 20, Number 3. March 2004

  • Overselling Donepezil (ARICEPT) and Exploiting Patients with Alzheimers Disease: Why Isn’t The FDA Stopping These Ads?
  • New Jersey Slow to Police Problem Physicians
  • Outrage: Kidney Dialysis Facilities: Serious Problems of Compliance with Medicare Quality Standards

Volume 20, Number 2, February 2004

  • Study Shows National Health Insurance Could Save $286 Billion on Health Care Paperwork
  • Product Recalls
  • Canada Outdoes U.S. on Flu Vaccine Policy
  • How to Achieve Positive Results Without Really Lying
  • Outrage: AARP and Medicare Legislation

Volume 20, Number 1, January 2004

  • Breast Cancer: New Information About Screening Mammography and Genetics
  • Product Recalls
  • Health Letter Volume Index 2003 and Cumulative Index
  • Outrage: National Institute of Mental health Fails to Fund Important Mental Health Research

Volume 19, Number 12, December 2003

  • Documentary Shows Problems in Pharmaceutical Industry, FDA
  • Product Recalls
  • FDA Issues Public Health Advisory On Antidepressants and Suicide Risk in Children
  • How to Report Adverse Reactions to the FDA
  • Outrage: Do Not Use: Dangerous Antidepressant Nefazodone (SERZONE) Withdrawn From the Market in Canada

Volume 19, Number 11, November 2003

  • A Conversation With Sheldon Krimsky: Uncoupling Campus and Company
  • Advertising Dietary Supplements on the Internet: Supplementing Income Rather than
  • Health
  • Product Recalls
  • Do Not Use: Asthma Drug Montelukast (SINGULAIR) for the Treatment of Hay Fever
  • Outrage: We Have Met the Enemy and He is Us

Volume 19, Number 10, October 2003

  • A New Health Care Gimmick: Concierge Medicine
  • Do Not Use: Rosuvastatin (CRESTOR) — A New But More Dangerous Cholesterol-Lowering “Statin” Drug
  • A Reminder About the Dangerous of Aspirin and Reye’s Syndrome
  • Product Recalls
  • Meridia — Weight Loss or Health Loss?
  • Outrage: Food and Drug Disaster

Volume 19, Number 9, September 2003

  • Sweetening the Pill
  • CPSC Says Consumers Continue to Use Dangerous Products Despite Recalls, Warnings
  • Product Recalls
  • Outrage: FDA-Approved Patient Information Needed

Volume 19, Number 8, August 2003

  • Profitably Inventing New Diseases The pharmaceutical industry cashes in by "creating" diseases
  • Secret No More Medicare investigation results now fair game
  • Product Recalls From sunscreen to extension cords: watch out!
  • Bad Medicine Why Bush's malpractice policy will only help insurers
  • Outrage of the month Taxol: How the NIH gave away the store

Volume 19, Number 7, July 2003

  • The Big Fix: A Book Review: How the pharmaceutical industry rips off American consumers
  • Product Recalls
  • Outrage of the Month: How Bayer shipped HIV-containing blood products to Asia and Latin America

  Volume 19, Number 6, June 2003

  • Doctor, Advocate, Activist
  • Health Research Group Ranks Medical Boards
  • Product Recalls
  • Resisting Antibiotic-Resistant Bacteria
  • Outrage: Democracy by Disclosure: A Book Review

Volume 19, Number 5, May 2003

  • Ephedra: Scientific Evidence Versus Money/Politics
  • Calcium By Any Other Name is Still Calcium
  • Bereavement
  • Product Recalls
  • Outrage: The Uncovering of an Undercoder: A Story of Medicine Triumphant

Volume 19, Number 4, April 2003

  • Cost, Quality and Choice: Winning Less Expensive, Better Quality Health Care For America
  • Affordable Reform That Benefits Patients
  • The Dangers of Some Screening Tests
  • A Free Ride for Bad Doctors
  • Product Recalls
  • Outrage: Nexium Offers Unique Advantage Over Generic Omeprazole

Volume 19, Number 3, March 2003

  • Selling "New" Drugs Using Smoke and Mirror (Images)
  • Foggy Thinking as Inhaled Flu Vaccine Nears FDA Approval
  • Product Recalls
  • MedWatch Reporting Form
  • Outrage: U.S. Air Force Flies High on Dexedrine

Volume 19, Number 2, February 2003

  • Medical Errors, Not Lawsuits, are Real Cause of Rising Malpractice Insurance Premiums
  • Inadequate Doctor Discipline by State Medical Boards
  • Government Publishes Adult Immunization Schedule
  • Product Recalls
  • Tamoxifen for Breast Cancer Prevention?
  • Outrage: Wanna Quit Smoking? Who you Gonna Call? Philip Morris?

Volume 19, Number 1, January 2003

  • "Neglected to Death:" The Scandalous Condition of American Nursing Homes
  • Product Recalls
  • Phyllis McCarthy Annual Public Interest Award
  • Health Letter Volume Index, 2002 and Cumulative Index
  • Remedies Needed to Address the Pathology in Reporting Adverse Reactions and Food and Drug Administration Use of Reports

Volume 18, Number 12, December 2002

  • 25,00 U.S. Deaths a Year Because of For-Profit Kidney Dialysis
  • Low Quality HMOs Hide Performance Data from Public, Says Journal of the American Medical Association Study
  • Blind to the Data: OSHA Looks the Other Way as Workers Exposed to Hexavalent Chromium
  • Product Recalls
  • Drug Safety Withdrawals: Who is Responsible for Notifying Patients?
  • "Dangerous Political Cowardice:" FDA Fails to Ban Dietary Supplement Ephedra
  • Outrage: The Corruptible Academic-Industry Partnership

Volume 18, Number 9, November 2002

  • Unsafe Drugs: Congressional Silence is Deadly (Part 2)
  • FDA Caves In to Industry, Fails to Adequately Address Tylenol Overdoses
  • Product Recalls
  • High Blood Pressure in the Physician’s Office?
  • Alzheimer’s Disease: Major Market Here to Stay
  • Outrage: GAO Report Backs Link Between Drug User Fees and Higher Rate of Drug Withdrawals

Volume 18, Number 8, October 2002

  • ADAPT Trial for Alzheimer’s Disease Prevention Should Be Canceled
  • Will a Vitamin a Day Keep the Doctor Away?
  • Questionable Doctors Online
  • Product Recalls
  • Outrage: Strange Bedfellows: How the Tobacco and Drug Industries Collaborated to Undermine Anti-Smoking Efforts

Volume 18, Number 8, September 2002

  • The Invisible Plague: The Rise of Mental Illness from 1750 to the Present
  • Update on the Illegal Promotion of Gabapentin (Neurontin)
  • Product Recalls 
  • Pressure On to Ban Ephedra
  • West Nile Virus Activity
  • Outrage: Health Research Group Asks for Metabolife President to be Investigated

Volume 18, Number 8, August 2002

  • Ethical Implications of Cosmetic Surgery for Aging
  • Product Recalls
  • Is Your Doctor Selling You to the Highest Bidder?
  • Hormone Replacement Therapy
  • Outrage: "It’s Botox Night at Hopkins"

Volume 18, Number 7, July 2002

  • Big Pharma Buys Psychiatry: An Aura of Scandal
  • Product Recalls
  • Conflict of Interest?
  • Nicotine Lollipops: Sweet, Addictive and Illegal
  • Cancer.gov
  • Ten Years Ago Today
  • Outrage: Department of Health and Human Services Fails to Ban Ephedra or Issue Adequate Warnings

Volume 18, Number 6, June 2002

  • Questionable Doctors Online: Disciplined Doctor Resource Debuts on Public Citizen Web Site in June
  • Understanding Risks — and the Risks You Run by Misunderstanding Them
  • Overworked Doctors Walk Off the Job
  • Product Recalls
  • Preventing Heat Induced Death and Illness
  • Outrage: New Study: Wait Seven Years to Use New Drugs

Volume 18, Number 5, May 2002

  • Public Citizen’s Health Research Group Ranking of State Medical Board Disciplinary Actions in 2001
  • Survey of Doctor Disciplinary Information on State Web Sites
  • Product Recalls
  • Outrage: Possible Corruption at the American Heart Association

Volume 18, Number 4, April 2002

  • Saving Your Sight — Early Detection is Critical
  • Nursing Homes: More Can Be Done to Protect Residents from Abuse
  • Product Recalls
  • Outrage: No Care for the Care Givers

Volume 18, Number 3, March 2002

  • Direct-To-Consumer Advertising — Education or Emotion Promotion?
  • Analysis: HMOs Try New Approach to Keep Drug Cost Down
  • Rx Needed for Medical Journals
  • Product Recalls
  • Outrage: We Wish this Hospital Well

Volume 18, Number 2, February 2002

  • The Destruction of Medicine by Market Forces: Teaching Acquiescence or Resistance and Change?
  • Good Business Suggestions [Business Week on controlling drug costs]
  • Product Recalls
  • Health Research Group Asks New Mexico to Sanction Doctor
  • New Study Shows Low Income Minority Seniors Restrict Use of Prescription Drugs
  • What Ails the Mass. Board of Medicine?
  • FDA Action on Red Cross Long Overdue
  • Canadians Begin Recall of Dangerous Drug Supplement Ephedra
  • Outrage: The AMA Does It Again

Volume 18, Number 1, January 2002

  • What’s New In Screening Mammography
  • Product Recalls
  • Clearing the Smoke from Low-Tar and Nicotine Cigarettes
  • Health Letter Volume Index 2001 and Cumulative Index
  • Outrage: Oops — Did It Again (or, Escondido in Escondido)

Volume 17, Number 12, December 2001

  • "You Can’t Leap a Chasm in Two Jumps"
  • Product Recalls
  • "...Makes You Stop and Think!"
  • Philip Morris Brags About its Killer Cigarettes
  • Living and Dying
  • DEA Promotes Public Citizen Information
  • Outrage: "I Have Never Seen Anything Like This"

Volume 17, Number 11, November 2001

  • Insufficient Credits
  • Drugs for Possible Exposure to Anthrax: What Makes Sense?
  • An Epidemic of Lung Disease Caused by a Quarter-Century of Government Inaction
  • Product Recalls
  • Colds: How to Treat Them
  • Outrage: The Lupron Loophole — and the Doctors Who Exploited It

Volume 17, Number 10, October 2001

  • Health Care Reform Coming? Don’t Bet the Farm On It
  • Unsafe Drugs: Congressional Silence Is Deadly
  • Product Recalls
  • Outrage: Do Not Use Ephedra

Volume 17, Number 9, September 2001

  • Criminal Charges Should Be Filed Against Schering-Plough
  • Direct-to-Consumer (DTC) Ads: Illegal, Unethical or Both
  • Below the Beltway
  • Product Recalls
  • Outrage: Crouching Government, Hidden Snake Oil

Volume 17, Number 8, 2001

  • In Memory of Our Colleague Henry Bergman
  • Questionable Hospitals
  • Product Recalls
  • Outrage: Darvon, Darvocet, Darvon Compound

Volume 17, Number 7, July 2001

  • Hormone Therapy: Doubts Grow
  • Drug Companies’ Antics Can Really Make You Sick
  • Product Recalls
  • Why Doesn’t the Government Know About These Doctors?
  • Outrage: "Operation Cure.All" Wages New Battle in Ongoing War Against Internet Fraud

Volume 17, Number 6, June 2001

  • Public Citizen Petitions OSHA to Limit Residents’ Working Hours
  • Preventing Heat-Induced Death and Illness
  • Product Recalls
  • Outrage: Lontronex and the FDA: A Fatal Erosion of Integrity

Volume 17, Number 5, May 2001

  • Public Citizen’s Health Research Group Ranking of State Medical Board
  • Disciplinary Actions in 2000
  • How to Reduce the Risk of Mad Cow Disease in the United States
  • Product Recalls
  • Outrage: Dietary Supplements: The FDA Should Do More

Volume 17, Number 4, April 2001

  • Latin America: the Answer to Drug Companies' Problems?
  • Election 2000 Commentators
  • Product Recalls
  • One Drug Company--Shering-Plough--Faces Massive Recalls
  • High Drug Prices for Research or Profit?
  • Is This Doc Deadly? His Practice Hasn't Been Perfect
  • Outrage: CASHCOW--Here a Moo, There a Moo

Volume 17, Number 3, March 2001

  • Is the U.S. Safe from Mad Cow Disease? Could We Be Safer?
  • Still Hard to Swallow
  • Product Recalls
  • It's the Calories that Count
  • COX-2 Inhibitors Vioxx and Celebrex: Keep Staying Away
  • Consumer Product Safety Commission Finally Sees the Light on Lead in Candles
  • Outrage: A Discussion of Misleading Drug Ads

Volume 17, Number 2, February 2001

  • Unhealthy Partnership: How Massachusetts and Its Managed Care Contractor Shortchange Troubled Children
  • Bad Policy, Worse Medicine
  • Let the ‘Non-Governments' Beware: Multinational Organizations Are Out to Co-opt You and Your Tactics
  • Product Recalls
  • Outrage: None of Your Business

Volume 17, Number 1, January 2001

  • FDA Fails to Get the Point on Safe Needles for Health Care Workers
  • Sex Education Information on the Internet: Caveat Emptor!
  • Product Recalls
  • Volume Index, 2000 and Cumulative Alphabetic Index
  • Outrage: FDA Accuses Red Cross of Jeopardizing the Safety of the Blood Supply

Volume 16, Number 12, December 2000

  • Is U.S. Health Really the Best in the World?
  • Osteoporosis
  • A Better Quality Alternative: Single Payer National Health Reform
  • Medical Fluoroscopy: Radiation-induced Skin Injury
  • Product Recalls
  • Outrage: America's Ailing Medical Education System

Volume 16, Number 11, November 2000

  • Review of Calcium Supplements; Ads Exaggerate Differences
  • Long-Acting Calcium Channel Blockers Inferior to Older Blood Pressure
  • Lowering Drugs in Preventing Heart Attacks and Heart Failure
  • When is a Patient Group Not a Patient Group?
  • Product Recalls
  • Television and Obese Children: A Strong Connection
  • Sitting Backwards is Safer
  • HRG Petitions the FDA to Ban Dangerous Diet and Cough/Cold Drugs in Over-the Counter Products
  • Outrage: "Too Much Corporate Power"

Volume 16, Number 10, October 2000

  • Epilepsy
  • How To Report Adverse Reactions to the Food and Drug Administration
  • Product Recalls
  • Outrage: Victimizing the Vulnerable

Volume 16, Number 9, September 2000

  • 20,125 Questionable Doctors
  • Product Recalls
  • Outrage: Human Experimentation for Profit

Volume 16, Number 8, August 2000

  • The Pharmaceutical Industry--To Whom is It Accountable?
  • Hundreds of Thousands of Workers at Risk from Hexavalent Chromium, Study Obtained Through FOIA Shows
  • Product Recalls
  • Report Estimates Air Lead Levels from Some Candle Wicks at Up to 36 Times EPA Standards
  • The Risks of Tranquility
  • Outrage: Erroneous and Misleading Reports in Media About Prescription Drugs

Volume 16, Number 7, July 2000

  • Patients' Rights Bills
  • Bereavement
  • Product Recalls
  • Outrage: Inspector General's Study on Human Experimentation

Volume 16, Number 6, June 2000

  • Kids First? How Vaccination Politics Can Undermine Public Health
  • Product Recalls
  • eLetter Web Site Launched on Drugs for the Seriously Mentally Ill
  • Doctors or Nurses - Does it Really Make a Difference?
  • Summer: How to Protect Yourself
  • Dangerous Gap in the Drug Safety System
  • Canadian Update on the Drug Celecoxcib (CELEBREX) Confirms HRG Warning
  • Outrage: Mother Dies, But Son Can't Get Explanation Because Her Doctor Won't OK Inquiry's Disclosure

Volume 16, Number 5, May 2000

  • Ranking of State Medical Board Disciplinary Actions in 1999
  • Do Not Use This Drug: Propulsid Withdrawn from the Market
  • Product Recalls
  • Loyalty in Government Service - to Whom?
  • Reducing Dangers to Pregnant Women
  • Outrage: Drkoop.CON: America's Family Doctor and his Conflicts of Interest, Part II

Volume 16, Number 4, April 2000

  • Safety Alert! It Is Better to Curse the Darkness Than to Light This Kind of Candle
  • St. John's Wort: A Growing List of Harmful Drug Interactions
  • Medicare: Few Beneficiaries Use Colorectal Cancer Screening and Diagnostic Services
  • Product Recalls
  • Patients, Doctors Not Warned of Dangers of New Diabetes Drugs
  • Outrage: Health News Feels the Censor's Knife

Volume 16, Number 3, March 2000

  • Survey of Doctor Disciplinary Information on State Medical Board Web Sites
  • Untested Herbs and Food Supplements for Pregnant Women Making the FDA Retract its Dangerous Regulation
  • Product Recalls
  • New Concerns About Menopausal Hormones and Breast Cancer
  • Outrage: The Unkindest Cut of All: Unnecessary Episiotomies

Volume 16, Number 2, February 2000

  • Managed Costs, Mismanaged Care
  • Primary Care in the United States - The Best of Times, the Worst of Times
  • Trust Me, I'm a Patient
  • Hollywood Hails a Tobacco Whistle Blower
  • Product Recalls
  • Debate on FDA's Recent Decision on Herbal Products
  • Outrage: Flu Epidemic May Be Just a Flu Advertisement

Volume 16, Number 1, January 2000

  • Wrong Prescription: Bill Bradley's Health Plan is No Cure
  • For-Profit Kidney Dialysis Centers Compromise Kidney Care
  • Point/Counterpoint: Is it Ethical to Pay Research Subjects Large Sums?
  • Product Recalls
  • Health Letter Volume Index for 1999 and Cumulative Index for 1985-1999
  • Outrage: Study Shows Widespread Medical Errors

Volume 15, Number 12, December 1999

  • ‘Hope Lodge' Movement Offers Hope to Cancer Patients Away from Home
  • Medical Merger
  • Product Recalls
  • The Grass Really is Greener to the North
  • Important Safety Reminder - Reye's Syndrome and Aspirin
  • Some More Questions About Your HMOs
  • The Science of Arresting Human Intelligence Long Enough to Get Money from It
  • Outrage: Milton, Matthew and Managed Care

Volume 15, Number 11, November 1999

  • Losing Weight: The Truth is Hard to Swallow
  • Product Recalls
  • Another Medical Myth Laid to Rest
  • Outrage: Bradley and Gore Rehash Stale Ideas

Volume 15, Number 10, October 1999

  • Clinton Administration Scuttles Worker Protections
  • An Interview with Breastfeeding Advocate and Formula Fighter Bobbi Philipp, M.D.
  • "Try It, You'll Like It" - For a Hefty Price: The Drugmaker's Scam on the Public
  • When Money is the Mission - The High Costs of Investor-Owned Care
  • Product Recalls
  • Outrage: Doctors and Rexall Combine to Push Worthless Dietary Supplements to Patients

Volume 15, Number 9, September 1999

  • Fraudulent Health Claims: Don't Be Fooled
  • Product Recalls
  • Off-Label Dangers
  • Young Children Continue to Die Unnecessarily on U.S. Farms
  • Outrage: Pfizer Caught Trying to Subvert National Guidelines for Treating Children's Ear Infections

Volume 15, Number 8, August 1999

  • Below the Beltway
  • Second Opinion: Temptation Makes a House Call
  • Product Recalls
  • Health Talk: Doctors Online
  • Worse Quality Medical Care in For-Profit HMOs Than in Not-for-Profits
  • Outrage: Dr. Koop: Part I

Volume 15, Number 7, July 1999

  • Preventing Heat-Induced Death and Illness
  • The Wild, Wild Web
  • Safety of Speedy FDA Drug Approval Being Questioned
  • Asleep on the Job
  • Product Recalls
  • Workplace Deaths: Where is the Federal Prosecution of Employers?
  • Outrage: Star Wars and Drugs

Volume 15, Number 6, June 1999

  • Public Citizen's Health Research Group Petitions the FDA to Revise Labeling on the Breast Cancer Drug Tamoxifen (NOLVADEX)
  • In the Public Interest
  • In Memoriam: John O. Nestor, M.D.
  • Product Recalls
  • Dangerous Drug Information on the Internet from Aetna/US Healthcare and Johns Hopkins
  • Outrage: Prescription Drug Profiles --- Accessible to All?

Volume 15, Number 5, May 1999

  • Public Citizen's Health Research Group Ranking of State Medical Board Disciplinary Actions in 1998
  • International Research Ethics Code Under Siege
  • Notes from Sidney Wolfe's Mom
  • Nurses, Patients and Managed Care
  • Product Recalls
  • Outrage: The Troglitzone (Rezulin) Safety Meeting

Volume 16, Number 4, April 1999

  • Adverse Drug Reactions
  • Crazy About Sex [Problems]
  • Preventing Osteoporosis, Falls and Fractures in Older Adults
  • Medicare Must Cover Prescription Drugs and Control Prices
  • The ACLU's Tobacco Addiction, Continued
  • Product Recalls
  • Outrage: Lessons from the George Lundberg Firing

Volume 15, Number 3, March 1999

  • The New Edition of Worst Pills, Best Pills
  • Serious Health Insurance Problems
  • Exhaustion that Kills
  • Product Recalls
  • Outrage: The FDA and Abbott Are Comfortable

Volume 15, Number 2, February 1999

  • "Going Bare": Uninsured Portion of U.S. Population Is Growing Rapidly, Survey Discloses
  • The Drug Approval Process
  • Product Recalls
  • A Dirty Little Secret: Managed Care is Bad of Business
  • Outrage: One More Hoax: The Neediest Would Get No Benefit from Clinton's Proposed Tax Credit

Volume 15, Number 1, January 1999

  • FDA Medical Officers Report Lower Standards Permit Dangerous Drug Approvals
  • Healthy Patients and Wealthy HMO Stockholders: An Impossible Mix
  • Product Recalls
  • Health Letter Volume Indices, 1997 and 1998
  • Health Letter Cumulative Alphabetical Index
  • Outrage: Andy Rooney: The Tobacco Deal

Volume 14, Number 12, December 1998

  • FDA's Controversial Decision: Tamoxifen (Nolvadex) Approved to Reduce the Risk of Breast Cancer HMO Medicare Crisis: Is Health Insurance for the Elderly on the Way Out?
  • Just Health Care
  • Product Recalls
  • Outrage: The ACLU's Tobacco Addiction

Volume 14, Number 11, November 1998

  • Inequities Documented in Medicare's Kidney Transplant Program
  • Effects of Anti-theft and Metal Detector Systems on Some Medical Devices
  • The Pitfalls of Untested "Alternative Medicine" Remedies
  • Product Recalls
  • What Role for Chiropractic in Health Care
  • Outrage: Number of Americans Without Health Insurance Jumps to 43.2 Million

Volume 14, Number 10, October 1998

  • U.S. Multinational Tobacco Companies' Double Standards Exposed
  • Health Letter 10 Years Ago
  • Product Recalls
  • Don't be a Casualty on the Information Super Highway
  • Major Access Barriers Identified in 10-State Health Insurance Study
  • Outrage: Merck Drug, Mark McGwire and Barbecue

Volume 14, Number 9, September 1998

  • Toward Universal Coverage
  • Breast Implants: The Debate Continues
  • Which Side of the Street is the AMA Working?
  • International Comparison of Drug Prices
  • Product Recalls
  • Outrage: Maliciously Blurring the Line Between News and Advertising

Volume 14, Number 8, August 1998

  • Public Citizen's HRG Petitions the FDA about Sildenafil (Viagra)
  • Product Recalls
  • Focus: Rush to Market
  • Medical Horror Stories: A Sign of a Health Care System in Crisis

Volume 14, Number 7, July 1998

  • Worst and Best Types of HMOs
  • Product Recalls
  • Outrage: Dangers to Participants in Human Experimentation

Volume 14, Number 6, June 1998

  • Cataracts In Adults: A Patient's Guide
  • Cataract Surgery Is This Trip Really Necessary?
  • Product Recalls
  • Preventing Heat-Induced Death and Illness
  • Doctors Need Patient's Help to Report Adverse Reactions to Drugs and Devices
  • Outrage: High-Heeled Shoes -- An Important Health Hazard

Volume 14, Number 5, May 1998

  • Public Citizen Health Research Group Ranking of State Medical Board
  • Disciplinary Actions in 1997
  • Dozens of Thai Infants Were Needlessly Infected with HIV in Unethical U.S. Govt-Funded Study
  • Product Recalls
  • Making A Difference: Can One Lone Consumer Persuade a Major Pharmaceutical Company to Change and Improve its Product?
  • Call For a Doctor! And Call...and Call...and Call
  • Switching Sides
  • Outrage: American Cancer Society and American Health Association

Volume 14, Number 4, April 1998

  • Prescription for Privacy
  • Private Care in Canada
  • Product Recalls
  • Aging and Your Eyes
  • Outrage: Questionable Doctors in Your HMO

Volume 14, Number 3, March 1998

  • 16, 638 Questionable Doctors
  • Health Insurance: Physical Abnormalities as Barriers to Treatment
  • Product Recalls
  • Access to Health Care: Some Nibbles and a Bite
  • Criminalizing Medical Malpractice
  • Is It Time to Quit the AMA?
  • Nutri/System Diet Clinics -- Dealing Diet Drugs

Volume 14, Number 2, February 1998

  • Powdered Latex Gloves Pose Serious Risk
  • An Appreciation: Esther Peterson 1906-1997
  • Product Recalls
  • Grim Details Under the Headlines
  • First, Do No Harm (Pending Prior Approval)
  • Unproven "Anti-Aging" Hormones Promise Youth
  • Bone Up! Choose Foods that are High in Calcium
  • Outrage: Direct-to-Consumer Hucksterism

Volume 14, Number 1, January 1998

  • Hospital Emergency Rooms and Patient Dumping
  • For Patients, Not Profits
  • Product Recalls
  • Bugs Causing Food Poisoning
  • Health Letter Indexes
  • Outrage: There They Go Again: The Joint Commission Protects Potentially Dangerous Hospitals

Volume 13, Number 12, December 1997

  • Long-Term Care Insurance: To Buy or Not To Buy, That is the Question
  • Who Poisoned the Children?
  • Stings and Strings: One Couple's Struggle with a Health Plan's Gatekeepers
  • Qui Tam: "Whistle-Blower" Lawsuits Recover Government Health Care Dollars
  • Product Recalls
  • Outrage: The "Benefits" of Sterility-Causing Chemicals in the Workplace?

Volume 13, Number 11, November 1997

  • Stadol -- User Beware
  • FTC Consumer Alert; Paunch Lines: Weight Loss Claims Are No Joke for Dieters
  • FDA Alerts: The Stimulator; Home-Use Test Kits
  • First, Do Nothing: Harvard Docs Announce "HMO Black"
  • Product Recalls
  • Managed Care: Doctors' Perspectives
  • Outrage: Columbia/HCA's Response to a Patient's Death: "You Know, We All Are Going to Die"

Volume 13, Number 10, October 1997

  • Experts Urge Steps to Stem Antibiotic Resistance
  • Budget Balancing: Medicare Savings, Medicaid Savings, and Other Shenanigans
  • Prescription for Trouble
  • If you Thought Our Health Care System Was Doing O.K., Note Some Contributions from Our Readers
  • Product Recalls
  • Outrage: "Whistle-Blower" Lawsuits Continue to Recover Millions of Health Care Dollars for the Government

Volume 13, Number 9, September 1997

  • HMO's Arbitration Process Provides Delay, Not Justice
  • The HMO That Ate the High School
  • Managed Care vs. Medical Care
  • Protecting the Corporate Bottom Line: The Narrow Therapeutic Index (NTI)
  • Drug Scam
  • Health Risks of the Internet
  • Product Recalls
  • Outrage: AMASCAM

Volume 13, Number 8, August 1997

  • Health Care, Will Care Be There?
  • The Politics of Mammography
  • Abnormal Moles Found to Increase Risk for Melanoma
  • Hormones: Correction and Additions
  • Product Recalls
  • Outrage: Booze, Pool and (??) School

Volume 13, Number 7, July 1997

  • Physicians Disciplined for Sex-Related Offenses
  • Long Term Care: Who Pays? The New Laws
  • Doctor-Run HMOs
  • Product Recalls
  • Outrage: Another Insurance Company Story

Volume 13, Number 6, June 1997

  • Sometimes Mother Nature Knows Best
  • Snapshots of Our Health Care System
  • Physician-Induced Hospitalization
  • Drugs: Over-the-Counter and On the Street
  • Product Recalls
  • Outrage: Halt 'Unethical' HIV Experiments Abroad Public Citizen Exhorts HHS Head Shalala

Volume 13, Number 5, May 1997

  • Ranking of State Medical Licensing Boards -- 1996
  • Growing Number of Investigations Focus on Questionable Practices by Columbia/HCA
  • Health Care: Coping with Terminal Illness: A Personal Perspective
  • Product Recalls
  • Medigap Insurance: Consumer Choice, Consumer Dilemma
  • Outrage: Idaho: Dangerous Delays in Doctor Discipline

Volume 13, Number 4, April 1997

  • For-Profit Hospitals Costlier, Less Efficient and Spend Less on Patient Care
  • Qui-Tam Lawsuits Recover Millions of Health Care Dollars for the Government
  • Study Finds High Incidence of Serious Errors in Hospitals
  • Frequently Asked Questions About Health Care
  • Product Recalls
  • Diversity in Doctors Providing Quality and Accessible Care for All
  • Birth Control Pills and Emergency Contraception
  • Outrage: Another Chicken Guarding Another Group of Foxes

Volume 13, Number 3, March 1997

  • Annotation: Patients on the Auction Block
  • HMO: Managed or Mangled?
  • Product Recalls
  • Mergers, Buyouts: A Tale of Three Cities
  • Pet Cemetery?
  • Outrage: The Health Insurance Industry's Dirty Little Secret

Volume 13, Number 2, February 1997

  • License to Steal: Why Fraud Plagues America's Health Care System
  • Michigan Orders Golden Rule to Issue Refunds
  • A Tragic Insulin Overdose
  • Diabetes: Insurance Coverage
  • The Changing Ways of the HMO Industry: Staff-and Group-Model HMOs Are Finding It Harder to Compete
  • Medical Discipline: Shroud of Secrecy
  • Welcome to Managed Caring®
  • Median Income for Doctors Hits $160,000 in 1995
  • Consumer Product Safety Alert
  • Food Labeling: Consumer Alert
  • Outrage: California HMO Fined $500,000 for Failing to Refer Patient to Specialist

Volume 13, Number 1, January 1997

  • Book Review: How HMOs Are Destroying Medical Trust
  • Do Not Ask for Whom the HMOs Merge...
  • Drug Recalls
  • Health Letter Indexes: Volume Index 1995 and 1996; Cumulative Subject Index
  • Outrage: There are Few Willing to Fight the Rampaging HMO Monsters